An integrated genomic approach to the assessment and treatment of acute myeloid leukemia

Seminars in Oncology

Volumn 38, Issue 2, 2011, Pages 215-224

  Godley, Lucy A ^a   Cunningham, John ^a   Dolan, M Eileen ^a   Huang, R Stephanie ^a   Gurbuxani, Sandeep ^a   McNerney, Megan E ^a   Larson, Richard A ^a   Leong, Hoyee ^a   Lussier, Yves ^a   Onel, Kenan ^a   Odenike, Olatoyosi ^a   Stock, Wendy ^a   White, Kevin P ^a,b   Le Beau, Michelle M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTHRACYCLINE; ANTHRAQUINONE; CD135 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYTARABINE; CYTOCHROME P450 3A4; DAUNORUBICIN; DNA METHYLTRANSFERASE 3A; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; INTERLEUKIN 1BETA; JANUS KINASE 1; MICRORNA; MIXED LINEAGE LEUKEMIA PROTEIN; NUCLEOPHOSMIN; PEPTIDE TRANSPORTER 1; PROTEIN MDM2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTOME; UNINDEXED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHROMOSOME REARRANGEMENT; COPY NUMBER VARIATION; CYTOGENETICS; DNA METHYLATION; DNA SEQUENCE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; GENOME; HETEROZYGOSITY LOSS; HUMAN; MISSENSE MUTATION; NONSENSE MUTATION; ONCOGENE N RAS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LEUKEMIA, MYELOID, ACUTE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79952938789     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.01.003     Document Type: Article

References (75)

1. U. Bacher, S. Schnittger, and C. Haferlach Molecular diagnostics in acute leukemias Clin Chem Lab Med 47 2009 1333 1341
2. J.P. Radich, A.D. Zelenetz, and W.C. Chan NCCN task force report: molecular markers in leukemias and lymphomas J Natl Compr Canc Netw 7 Suppl 4 2009 S1 S34
3. J. Suela, S. Alvarez, and J.C. Cigudosa DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromes Cytogenet Genome Res 118 2007 304 309 (Pubitemid 350125270)
4. A.M. Gonzalez-Angulo, B.T. Hennessy, and G.B. Mills Future of personalized medicine in oncology: a systems biology approach J Clin Oncol 28 2010 2777 2783
5. J. Chen, O. Odenike, and J.D. Rowley Leukaemogenesis: more than mutant genes Nat Rev Cancer 10 2010 23 36
6. R.S. Huang, and M.E. Dolan Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020 Pharmacogenomics 11 2010 471 474
7. E.A. Eklund Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators Curr Opin Hematol 17 2010 75 78
8. G. Marcucci, M.D. Radmacher, and K. Mrozek MicroRNA expression in acute myeloid leukemia Curr Hematol Malig Rep 4 2009 83 88
9. U. Bacher, A. Kohlmann, and C. Haferlach Gene expression profiling in acute myeloid leukaemia (AML) Best Pract Res Clin Haematol 22 2009 169 180
10. M.J. Walter, T.A. Graubert, and J.F. Dipersio Next-generation sequencing of cancer genomes: back to the future Per Med 6 2009 653
11. T.J. Ley, E.R. Mardis, and L. Ding DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome Nature 456 2008 66 72
12. E.R. Mardis, L. Ding, and D.J. Dooling Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 361 2009 1058 1066
13. D.W. Parsons, S. Jones, and X. Zhang An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
14. G. Marcucci, K. Maharry, and Y.Z. Wu IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study J Clin Oncol 28 2010 2348 2355
15. L.D. Wood, D.W. Parsons, and S. Jones The genomic landscapes of human breast and colorectal cancers Science 318 2007 1108 1113 (Pubitemid 350134889)
16. T.R. Golub, D.K. Slonim, and P. Tamayo Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 286 1999 531 537
17. K. Mrozek, M.D. Radmacher, and C.D. Bloomfield Molecular signatures in acute myeloid leukemia Curr Opin Hematol 16 2009 64 69
18. L. Bullinger, K. Dohner, and R. Kranz An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML Blood 111 2008 4490 4495
19. M.D. Radmacher, G. Marcucci, and A.S. Ruppert Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study Blood 108 2006 1677 1683 (Pubitemid 44316137)
20. K.H. Metzeler, M. Hummel, and C.D. Bloomfield An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia Blood 112 2008 4193 4201
21. A. Kohlmann, T.J. Kipps, and L.Z. Rassenti An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase Br J Haematol 142 2008 802 807
22. M.E. Figueroa, S. Lugthart, and Y. Li DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia Cancer Cell 17 2010 13 27
23. S. Mi, J. Lu, and M. Sun MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia Proc Natl Acad Sci U S A 104 2007 19971 19976
24. C. Langer, G. Marcucci, and K.B. Holland Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study J Clin Oncol 27 2009 3198 3204
25. H. Becker, G. Marcucci, and K. Maharry Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study Blood 116 2010 788 792
26. S.P. Whitman, K. Maharry, and M.D. Radmacher FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study Blood 116 2010 3622 3626
27. R. Garzon, S. Volinia, and C.G. Liu MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia Blood 111 2008 3183 3189
28. M. Jongen-Lavrencic, S.M. Sun, and M.K. Dijkstra MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia Blood 111 2008 5078 5085
29. G. Marcucci, K. Maharry, and M.D. Radmacher Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study J Clin Oncol 26 2008 5078 5087
30. G. Marcucci, M.D. Radmacher, and K. Maharry MicroRNA expression in cytogenetically normal acute myeloid leukemia N Engl J Med 358 2008 1919 1928 (Pubitemid 351620112)
31. T. Akagi, S. Ogawa, and M. Dugas Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype Haematologica 94 2009 213 223
32. J. Huh, R.V. Tiu, and L.P. Gondek Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis Genes Chromosomes Cancer 49 2010 390 399
33. E. Serrano, M.J. Carnicer, and V. Orantes Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype Leuk Lymphoma 49 2008 1178 1183 (Pubitemid 351943265)
34. M.J. Walter, J.E. Payton, and R.E. Ries Acquired copy number alterations in adult acute myeloid leukemia genomes Proc Natl Acad Sci U S A 106 2009 12950 12955
35. L. Bullinger, J. Kronke, and C. Schon Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis Leukemia 24 2010 438 449
36. S. Heinrichs, C. Li, and A.T. Look SNP array analysis in hematologic malignancies: avoiding false discoveries Blood 115 2010 4157 4161
37. B. Parkin, H. Erba, and P. Ouillette Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia Blood 116 2010 4958 4967
38. T.J. Ley, P.J. Minx, and M.J. Walter A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes Proc Natl Acad Sci U S A 100 2003 14275 14280 (Pubitemid 37499227)
39. M.H. Tomasson, Z. Xiang, and R. Walgren Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia Blood 111 2008 4797 4808
40. Z. Xiang, Y. Zhao, and V. Mitaksov Identification of somatic JAK1 mutations in patients with acute myeloid leukemia Blood 111 2008 4809 4812
41. J. Jiang, J.G. Paez, and J.C. Lee Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML Blood 104 2004 1855 1858 (Pubitemid 39202297)
42. Y. Yamashita, J. Yuan, and I. Suetake Array-based genomic resequencing of human leukemia Oncogene 29 2010 3723 3731
43. P. Staib, E. Staltmeier, and K. Neurohr Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci Br J Haematol 128 2005 783 791 (Pubitemid 40444870)
44. L.A. Godley, and R.A. Larson Therapy-related myeloid leukemia Semin Oncol 35 2008 418 429
45. L.A. Godley, and R.A. Larson Therapy-related myelodysplastic syndrome and myeloid leukemia D.P. Steensma, Myelodysplastic syndromes: pathobiology and clinical management 2009 Informa Healthcare New York 173 194
46. C. Seedhouse, and N. Russell Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia Br J Haematol 137 2007 513 529 (Pubitemid 46817341)
47. R.A. Larson, Y. Wang, and M. Banerjee Prevalence of the inactivating 609C - >T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia Blood 94 1999 803 807 (Pubitemid 29323895)
48. P. Bolufer, M. Collado, and E. Barragan Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia Br J Haematol 136 2007 590 596 (Pubitemid 46148195)
49. J.M. Allan, C.P. Wild, and S. Rollinson Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia Proc Natl Acad Sci U S A 98 2001 11592 11597 (Pubitemid 32928773)
50. T. Naoe, K. Takeyama, and T. Yokozawa Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia Clin Cancer Res 6 2000 4091 4095
51. L. Fern, M. Pallis, and G. Ian Carter Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS Br J Haematol 126 2004 63 71 (Pubitemid 38859483)
52. V.M. Guillem, M. Collado, and M.J. Terol Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies Leukemia 21 2007 1413 1422 (Pubitemid 46969870)
53. L.J. Worrillow, L.B. Travis, and A.G. Smith An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents Clin Cancer Res 9 2003 3012 3020 (Pubitemid 36993261)
54. L.J. Worrillow, A.G. Smith, and K. Scott Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma J Med Genet 45 2008 142 146 (Pubitemid 351373742)
55. J.E. Churpek, and K. Onel Heritability of hematologic malignancies: from pedigrees to genomics Hematol Oncol Clin North Am 24 2010 939 972
56. C. Owen, M. Barnett, and J. Fitzgibbon Familial myelodysplasia and acute myeloid leukaemiaa review Br J Haematol 140 2008 123 132 (Pubitemid 350265048)
57. J.E. Churpek, J.S. Garcia, and J. Madzo Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder Leuk Lymphoma 51 2010 1931 1935
58. J.M. Maris, S.R. Wiersma, and N. Mahgoub Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1 Cancer 79 1997 1438 1446 (Pubitemid 27143252)
59. C.G. Mathew Fanconi anaemia genes and susceptibility to cancer Oncogene 25 2006 5875 5884 (Pubitemid 44453443)
60. C.A. Felix, M.R. Hosler, and D. Provisor The p53 gene in pediatric therapy-related leukemia and myelodysplasia Blood 87 1996 4376 4381 (Pubitemid 26152278)
61. N.A. Ellis, D. Huo, and O. Yildiz MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility Blood 112 2008 741 749
62. G.L. Bond, W. Hu, and E.E. Bond A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 119 2004 591 602 (Pubitemid 39535748)
63. G.L. Bond, K.M. Hirshfield, and T. Kirchhoff MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner Cancer Res 66 2006 5104 5110 (Pubitemid 43844932)
64. G.L. Bond, C. Menin, and R. Bertorelle MDM2 SNP309 accelerates colorectal tumour formation in women J Med Genet 43 2006 950 952 (Pubitemid 46080193)
65. P. Dumont, J.I. Leu, and A.C. Della Pietra 3rd The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 2003 357 365 (Pubitemid 36278852)
66. M. Thomas, A. Kalita, and S. Labrecque Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol Cell Biol 19 1999 1092 1100 (Pubitemid 29046852)
67. M.C. Marin, C.A. Jost, and L.A. Brooks A common polymorphism acts as an intragenic modifier of mutant p53 behaviour Nat Genet 25 2000 47 54 (Pubitemid 30257035)
68. T.A. Manolio Genomewide association studies and assessment of the risk of disease N Engl J Med 363 2010 166 176
69. J.A. Knight, A.D. Skol, and A. Shinde Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility Blood 113 2009 5575 5582
70. S. Duan, W.K. Bleibel, and R.S. Huang Mapping genes that contribute to daunorubicin-induced cytotoxicity Cancer Res 67 2007 5425 5433 (Pubitemid 46997283)
71. R.S. Huang, S. Duan, and E.O. Kistner Genetic variants contributing to daunorubicin-induced cytotoxicity Cancer Res 68 2008 3161 3168
72. T. Naoe, Y. Tagawa, and H. Kiyoi Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy Leukemia 16 2002 203 208 (Pubitemid 34145137)
73. C.M. Hartford, S. Duan, and S.M. Delaney Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity Blood 113 2009 2145 2153
74. J.K. Lamba Genetic factors influencing cytarabine therapy Pharmacogenomics 10 2009 1657 1674
75. T.A. Yap, S.K. Sandhu, and P. Workman Envisioning the future of early anticancer drug development Nat Rev Cancer 10 2010 514 523